| 000 | 01592 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515144220.0 | ||
| 264 | 0 | _c20081224 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2008.19.4118 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLejeune, Julien | |
| 245 | 0 | 0 |
_aEvidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2008 |
||
| 300 |
_a5489-91; author reply 5491-2 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinkage Disequilibrium |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aReceptors, IgG _xgenetics |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aWhite People _xgenetics |
| 700 | 1 | _aThibault, Gilles | |
| 700 | 1 | _aTernant, David | |
| 700 | 1 | _aCartron, Guillaume | |
| 700 | 1 | _aWatier, Hervé | |
| 700 | 1 | _aOhresser, Marc | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 26 _gno. 33 _gp. 5489-91; author reply 5491-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2008.19.4118 _zAvailable from publisher's website |
| 999 |
_c18417834 _d18417834 |
||